Replies to post #608611 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

HyGro,

I thought you would first give me some credit for pointing out the importance of RWE on DCVax-L as Musella posted an article from FDa.

https://www.fda.gov/news-events/fda-voices/facilitating-review-real-world-data-studies-oncology-qcard-initiative

The stuff you are talking about has been dissected many times on this board. It is no fun for me to rebutt.

[Horseb4CarT]

Fabrications and deceptions

[newman2021]

Did you not see the Adaptive Trial guidance released by the FDA. Also post hoc analysis guidance also was released by the FDA recently. What do these tell you??

[Reefrad]

You mean editorials, commentaries, not data driven articles. Worth much less.

[hoffmann6383]

False. SAP approved with RAs. Moot point. There is zero issue with the trial design.

[Roman516]

The real truth of the matter is that the comment,
"Seven journal publications have challenged the legitimacy of any conclusions for NWBO's P3 trial"
The seven-journal publication have near zero weighting factor compared to the 1000's of doctors, scientists, and professionals who all support NWBO.